1110: Kingworld Medicines Group Limited - Summary | Jitta

Kingworld Medicines Group Limited

HKG:1110

Price
HK$0.74
Loss Chance
44.2%
4.44JITTA SCORE
44.84%Under Jitta Line
Jitta Ranking
44 / 190
365 / 2,342
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (30)
Recent Business Performance (53)
Financial Strength (77)
Return to Shareholders (13)
Competitive Advantage (41)
Jitta Signs
Debt LevelLow Long Term Debt
Interest Coverage RatioVery Good
SG&A to SalesDecreasing
Revenue and EarningRevenue decline from 2019-2022
Recent Business PerformanceEarning decline 48.20% in the last quarter (yoy)
Key Stats
Jitta Score
Jitta Line
4.44
44.84%
3.66
696.35%
Health Care Distributors
4.88
37.01%
6.68
72.35%
5.49
56.10%
COMPANY DESCRIPTION
Kingworld Medicines Group Limited, an investment holding company, distributes branded imported pharmaceutical and healthcare products. The company also supplies pharmaceutical, healthcare, general foodstuffs, and medical products. It offers products for relieving cough, eliminating phlegm, soothing asthma, curing influenza, and other categories under the Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, Kingworld Imada Red Flower Oil, Culturelle probiotics product series, Lifeline Care product serices, and Mentholatum product series brands. The company also manufactures and sells electrotherapeutic and physiotherapeutic devices, and general medical examination devices. It serves in the People’s Republic of China, Hong Kong, the United States, the United Kingdom, Germany, Italy, Spain, Mexico, and internationally. The company was founded in 1996 and is headquartered in Shenzhen, the People’s Republic of China.